Insider Cluster (3 insiders) ·Filed Mar 16, 2026

CYRX

Cryoport, Inc.
NEUTRAL
Impact 4/10
Horizondays Processed6mo ago
Insider cluster: 2 insiders, $48K total
Actionable Insight • Neutral

Monitor for continued selling beyond this grant cycle; while current activity is routine, sustained outflows could signal concern. The lack of insider buying suggests no strong conviction in near-term upside.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
CYRX ▲ +93.50% at T+60d
NEUTRAL call ✓ call won +93.50% · α vs SPY +83.02% · entry $8.00 → $15.48
Entry anchored
Mar 13, 03:59 PM ET
via exchange tick
T+1d
+4.50%
call +4.50% · α +4.23%
$8.36
settled 7mo ago
T+5d
+1.88%
call +1.88% · α +3.92%
$8.15
settled 7mo ago
T+20d
+24.38%
call +24.38% · α +20.60%
$9.95
settled 6mo ago
T+60d
+93.50%
call +93.50% · α +83.02%
$15.48
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Three key executives at Cryoport — the CEO, CFO, and Chief Scientific Officer — sold shares in the past week, with total open-market sales amounting to $412K. These sales coincided with large non-cash stock grants totaling nearly 700,000 shares to the same insiders, likely tied to annual equity compensation. The net economic impact of the cluster is neutral, as the sales represent routine liquidity events following equity vesting.

Key Financial Metrics

Direction
selling
Total Value
$412.6K
Insiders
3

Key Facts

  • CEO Jerrell Shelton sold $63,344 worth of shares, CFO Robert Stefanovich sold $300,385, and CSO Mark Sawicki sold $25,880 — all via open-market transactions.
  • Total open-market sales: $412K, representing 0.1% of Cryoport's $399M market cap — below the threshold for material insider selling.
  • Concurrent with sales, insiders received non-cash stock awards totaling 681,533 shares, including 492,901 to the CEO, indicating a routine annual equity grant event.
  • CFO exercised options for 87,188 shares twice — once at $1.87 and once at $0 — followed by partial sale of proceeds.

Financial Impact

$412,000 in open-market sales; $0 net cash impact from grants and exercises

insider ownershippotential dilution

Risk Factors

  • Perception of insider selling may weigh on sentiment despite being post-vesting liquidity events.
  • Potential dilution from large stock awards if not offset by share buybacks or strong performance.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (11 trades, 7d window)cluster-CYRX-1773792040992
5 reports for CYRX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CYRX — sortable, filterable
TypeNow
Aug 14, 2026
7w ago
Institutional Cluster
BULLISH ★ 5/10
$15.25 $15.96▲ +4.66%▲ +6.65%$17.43 (+14.30%)
Jun 21, 2026
14w ago
Institutional Cluster
MIXED ★ 4/10
$14.77 $16.51▲ +11.78%▲ +11.93%$17.43 (+18.01%)
Jun 12, 2026
15w ago
Insider Cluster
NEUTRAL ★ 4/10
$14.83 $15.71▲ +5.93%▲ +6.68%$17.43 (+17.53%)
Mar 16, 2026
28w ago
Insider Cluster
NEUTRAL ★ 3/10
$8.00 $9.95▲ +24.38%▲ +20.60%$17.43 (+117.88%)
Mar 16, 2026
28w ago
Insider Cluster
NEUTRAL ★ 4/10
$8.00 $9.95▲ +24.38%▲ +20.60%$17.43 (+117.88%)
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (64h 16m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 18, 2026